GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » COGS-to-Revenue

Magle Chemoswed Holding AB (OSTO:MAGLE) COGS-to-Revenue : 0.08 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB COGS-to-Revenue?

Magle Chemoswed Holding AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr3.3 Mil. Its Revenue for the three months ended in Mar. 2024 was kr41.9 Mil.

Magle Chemoswed Holding AB's COGS to Revenue for the three months ended in Mar. 2024 was 0.08.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Magle Chemoswed Holding AB's Gross Margin % for the three months ended in Mar. 2024 was 92.02%.


Magle Chemoswed Holding AB COGS-to-Revenue Historical Data

The historical data trend for Magle Chemoswed Holding AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB COGS-to-Revenue Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.18 0.21 0.16 0.08 0.10

Magle Chemoswed Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 - 0.13 0.15 0.08

Magle Chemoswed Holding AB COGS-to-Revenue Calculation

Magle Chemoswed Holding AB's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=16.519 / 170.44
=0.10

Magle Chemoswed Holding AB's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3.345 / 41.902
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magle Chemoswed Holding AB  (OSTO:MAGLE) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Magle Chemoswed Holding AB's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 3.345 / 41.902
=92.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Magle Chemoswed Holding AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines